CorMedix Inc. Quarterly Selling and Marketing Expense in USD from Q2 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
CorMedix Inc. quarterly Selling and Marketing Expense history and growth rate from Q2 2023 to Q2 2024.
  • CorMedix Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $7.39M, a 127% increase year-over-year.
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.39M +$4.13M +127% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q2 2023 $3.26M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.